Amicus Therapeutics (FOLD) Earnings Date & Reports

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

FOLD is expected to report earnings to fall 120.33% to -1 cents per share on May 07

Amicus Therapeutics FOLD Stock Earnings Reports

Q1'25

Est.

$-0.02

Q4'24

Beat

by $0.08

Q3'24

Beat

by $0.10

Q2'24

Est.

$-0.05

Q1'24

Beat

by $0.04

The last earnings report on February 19 showed earnings per share of 9 cents, beating the estimate of 0 cents. With 4.77M shares outstanding, the current market capitalization sits at 2.46B.

View a ticker or compare two or three

Compare

FOLD